RYTM - Rhythm Pharmaceuticals Inc.
IEX Last Trade
47.39
1.290 2.722%
Share volume: 247,081
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$46.10
1.29
2.80%
Fundamental analysis
25%
Profitability
25%
Dept financing
12%
Liquidity
75%
Performance
15%
Performance
5 Days
2.54%
1 Month
-0.78%
3 Months
28.93%
6 Months
6.56%
1 Year
81.61%
2 Year
112.44%
Key data
Stock price
$47.39
DAY RANGE
N/A - N/A
52 WEEK RANGE
$20.97 - $53.92
52 WEEK CHANGE
$0.70
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Hunter Smith
Region: US
Website: http://www.rhythmtx.com
Employees: 199
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.rhythmtx.com
Employees: 199
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Recent news